Translational Immunocardiology

Our research is focused at exploring the role of the innate and adaptive immunity in the pathogenesis of non-ischemic heart failure with main interest in inflammatory cardiomyopathy and heart failure with preserved ejection fraction. The relevance of extra-cardiac versus cardiac inflammation on the pathogenesis of heart failure is investigated. In addition, our research is directed at the search for novel therapeutic targets as well as the evaluation of repurposed anti-inflammatory and immunomodulatory strategies.

Focus

In view of translational research, patient materials of specific heart failure cohorts are analyzed and identified targets and therapies evaluated in experimental models.

Publications

Van Linthout S - Search Results - PubMed (nih.gov)

• Pesce M, Duda GN, Forte G, Girao H, Raya A, Roca-Cusachs P, Sluijter JPG, Tschöpe C, Van Linthout S.  
  Cardiac fibroblasts and mechanosensation in heart development, health and disease - PubMed (nih.gov)
  Nat Rev Cardiol, 2022.
• Matz I, Pappritz K, Springer J, Van Linthout S.
  Left ventricle- and skeletal muscle-derived fibroblasts exhibit a differential inflammatory and metabolic responsiveness to interleukin-6 - PubMed (nih.gov)
  Front Immunol, 2022. 
• Pappritz K, Lin J, El-Shafeey M, Fechner H, Kühl U, Alogna A, Spillmann F, Elsanhoury A, Schulz R, Tschöpe C1, Van Linthout S¹.
  Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis - PubMed (nih.gov)
  ESC Heart Fail 2022
• Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Kelle S, Klingel K, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. 
  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions - PubMed (nih.gov)
  Nat Rev Cardiol 2021